Previous 10 | Next 10 |
Addex Therapeutics (ADXN) announces that the first patients have been enrolled into a Phase 2 clinical study evaluating JNJ-40411813 (ADX71149) in patients with epilepsy, being conducted in collaboration with Janssen Pharmaceuticals of Johnson & Johnson (JNJ). Data from the study are expe...
Addex Therapeutics (ADXN): Q1 GAAP EPS of -CHF0.08.Cash and cash equivalents of CHF25.2MPress Release For further details see: Addex Therapeutics reports Q1 results
Today’s analyst action includes Intuitive Surgical upgrade at Baird after better-than-expected Q1 earnings and positive catalyst watches opened at Citi on Abbvie and Bristol-Myers Squibb.Intuitive Surgical extends gains as Oppenheimer upgrades the stockIntuitive Surgical (ISRG) is exte...
Addex Therapeutics Limited (ADXN) Q4 2020 Earnings Conference Call March 11, 2021, 10:00 AM ET Company Participants Tim Dyer - CEO Roger Mills - Chief Medical Officer Robert Lutjens - Head of Discovery Biology Conference Call Participants Presentation Operator Ladies and gentlemen, welcome to...
Addex Therapeutics (ADXN): FY GAAP EPS of -CHF0.48.Revenue of CHF3.8M (+36.8% Y/Y)Press Release For further details see: Addex Therapeutics reports FY 2020 results
A new multi-year drug discovery agreement will focus on CNS drug discovery Enamine Ltd. a provider of drug discovery services empowered with the world’s largest collections of building blocks, fragments and screening compounds announced today that it has extended it...
Addex Therapeutics (ADXN) announces that a review published in Alcohol and Alcoholism suggests that positive allosteric modulators (PAMs) of the gamma-aminobutyric acid B (GABAB) receptor could offer a new treatment option for patients with severe alcohol use disorder ((AUD)).Addex’s G...
Gainers: Vinco Ventures (BBIG) +312%.ADiTx Therapeutics (ADTX) +90%.Qutoutiao (QTT) +65%.Ideal Power (IPWR) +51%.BiondVax Pharmaceuticals (BVXV) +39%.Celsion (CLSN) +34%.Polar Power (POLA) +33%.Addex Therapeutics (ADXN) +28%.Pioneer Power Solutions (PPSI) +27%.Barnwell Industri...
Gainers: ADiTx Therapeutics (ADTX) +63%, Celsion (CLSN) +58%, Genetic Technologies (GENE) +39%, Addex Therapeutics (ADXN) +26%, ThermoGenesis Holdings (THMO) +19%.Losers: Obalon Therapeutics (OBLN) -25%, Cancer Genetics (CGIX) -24%, ...
Vinco Ventures (BBIG) +265%.Genetic Technologies (GENE) +79% as COVID-19 risk test further enhances predictive capabilities.Celsion (CLSN) +65%.Addex Therapeutics (ADXN) +64% as ADX71149 receives IND approval to start a phase 2a clinical study in Epilepsy.INmune Bio (INMB) +39% ...
News, Short Squeeze, Breakout and More Instantly...
Addex Therapeutics Ltd Company Name:
ADXN Stock Symbol:
NASDAQ Market:
Addex Therapeutics Ltd Website:
Ad Hoc Announcement Pursuant to Art. 53 LR Geneva, Switzerland, July 22, 2024 - Addex Therapeutics (SIX and Nasdaq: ADXN), a clinical-stage biopharmaceutical company focused on developing a portfolio of novel small molecule allosteric modulators for neurological disorders, an...
2024-07-19 15:38:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
Ad Hoc Announcement Pursuant to Art. 53 LR Geneva, Switzerland, July 15, 2024 - Addex Therapeutics (SIX: ADXN and Nasdaq: ADXN), a clinical-stage biopharmaceutical company focused on developing a portfolio of novel small molecule allosteric modulators for neurological...